Aims Transvenous lead extraction (TLE) is performed using non-laser and laser techniques
with overall high efficacy and safety. Variation in outcomes between the two approaches …

Orthotopic transcatheter tricuspid valve replacement (TTVR) devices have been shown to be
highly effective in reducing tricuspid regurgitation (TR), and interest in this therapy is …

Infection related to cardiac implantable electronic devices (CIEDs) occurs in∼ 1%–3% of
cases during the device lifetime. 1 These include pocket infection, systemic infection, and …

Aims Transvenous lead extraction (TLE) of implantable cardioverter-defibrillator (ICD) leads
is considered challenging. The structure of each ICD leads is variable between …

Aims Transvenous lead extraction (TLE) is important in the management of cardiac
implantable electronic devices but carries risk. It is most commonly completed from the …

Background: Implantable cardioverter-defibrillator (ICD) leads are considered a risk factor
for major complications (MC) during transvenous lead extraction (TLE). Methods: We …

An increase in cardiovascular implantable electronic devices (CIEDs) and undoubtedly the
complications brought on by these devices coincide with an increase in cardiovascular …

Background Transvenous lead extraction (TLE) of cardiac implantable electronic devices
was once deemed highly risky by high-volume centers. However, advancements in …

Background: Nowadays, we observe a growing interest in conduction system pacing (CSP).
Therefore, we expect the number of patients with CSP to increase significantly in the coming …

Background The combination of pectoserratus plane block (PSP) and superficial serratus
anterior plane block (S-SAP) was established to reduce the risk of general anesthesia for …